FOLH1 and male reproductive organ cancer: In all 52 study patients in the 18F-PSMA cohort and in 97.2% (35/36) of the patients in the 68Ga-PSMA cohort, PSMA-avid prostate lesions were detected concordant with histopathologically proven PC.